Real-world outcomes with T-VEC in patients with anti-PD-1 resistant in-transit disease from melanoma and Merkel cell carcinoma

Autor: Su, David G. a, McNamara, Madeline b, Kaszycki, Margaret A. c, Frey, Alexander E. a, Ishizuka, Jeffrey J. d, Costa, Philippos A. d, Tran, Thuy T. d, Kluger, Harriet M. d, Clune, James E. e, Weiss, Sarah A. f, Olino, Kelly L. a, ⁎
Zdroj: In Surgical Oncology Insight March 2025 2(1)
Databáze: ScienceDirect